Citi raised the firm’s price target on Veeva (VEEV) to $349 from $329 and keeps a Buy rating on the shares. The firm views the company’s Q2 report as solid with large pharma trends intact.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva Systems: Strong Financial Performance and Strategic Positioning Drive Buy Rating
- Veeva price target raised to $355 from $325 at Piper Sandler
- Veeva price target raised to $341 from $326 at Wells Fargo
- Veeva Systems: Buy Rating Affirmed Amid Strong Q2 Performance and Promising Growth Opportunities
- Veeva Systems Reports Strong Q2 Earnings Growth